Cibenzoline is a Class III antiarrhythmic agent primarily indicated for the treatment and prevention of cardiac arrhythmias. By modulating cardiac action potential repolarization, membrane excitability,… Read more






Cibenzoline is a Class III antiarrhythmic agent primarily indicated for the treatment and prevention of cardiac arrhythmias. By modulating cardiac action potential repolarization, membrane excitability, and impulse conduction, this medication effectively stabilizes heart rhythm. In pharmaceutical development and manufacturing, rigorous quality control relies on the availability of high-quality analytical tools. This category includes Cibenzoline reference standards, including the active pharmaceutical ingredient, to support accurate potency testing and method validation. Furthermore, identifying and quantifying related substances is critical to regulatory compliance; therefore, this selection also provides access to pharmacopeial and non-pharmacopeial impurities. Laboratories also utilize stable isotope-labelled compounds, such as deuterated analogues, as internal standards in mass spectrometry to enhance precision during impurity profiling, bioanalytical method development, and pharmacokinetic studies, ensuring the consistent safety and efficacy of the final therapeutic product.